$DARE News Article - Dar Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO(TM) (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis
https://marketwirenews.com/news-releases/dar-...67822.html